Skip to main content
OpenTrials
Completed

NCT Number: NCT01882673

Motivating Quitline Use Among Smokers in Treatment for Substance Use Disorders

The long-term goal of this program of research is to disseminate an effective, brief computer-based intervention that can be readily integrated into Substance Use Disorders (SUD) treatment programs to motivate tobacco quitline use in patients who smoke. The overall objective of this application, which is the first step in the attainment of this long-term goal, is to fully develop this computer-based intervention, modify it based on initial piloting and feedback to insure its feasibility and acceptability, and obtain preliminary data supporting the efficacy of the intervention. This will be accomplished by pursuing three specific aims: 1) to develop and conduct preliminary pilot testing (n=20) of a brief, computer-based intervention intended to motivate tobacco quitline use among cigarette smokers in SUD treatment (TIME-TQ; Tablet computer Intervention to Motivate Engagement in Tobacco Quitline use) and to develop and pilot test a computer-based, time matched control intervention (CON), 2) to conduct a preliminary randomized controlled trial (RCT) with 60 smokers in SUD treatment, comparing TIME-TQ vs. CON, with predictions that TIME-TQ relative to CON will result in increased readiness, higher rates of tobacco treatment engagement, more quit smoking attempts and higher rates of 7-day point prevalence abstinence rates at 1- and 3-month follow-ups. Substance use outcomes over the course of the 3-month follow-up period will also be examined, and 3) to examine TIME-TQ's effects on key mechanisms during the computer session and their associations with tobacco treatment engagement and smoking outcomes at 1- and 3-month follow-ups.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Butler Hospital

Providence, Rhode Island, 02906, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • between 18 and 70 years of age
  • current smoker (i.e., at least 10 cigarettes per day)
  • current DSM-IV alcohol or drug abuse or dependence per SCID-P.

Exclusion criteria

  • history of psychotic disorder or current psychotic symptoms per the Structured Clinical Interview for DSM 4R - Patient version
  • cognitive impair-ment sufficient to impair provision of informed consent or study participation
  • current suicidality or homicidality
  • use of NRT or other pharmacotherapy for smoking cessation
  • use of other tobacco products

Treatment and study plan

Brief Computer Motivational Interviewing for Smoking Cessation

Behavioral

Brief computer motivational interviewing intervention to motivated tobacco quitline use

Nutrition Control

Behavioral

Computer delivered nutrition education control condition

Primary outcomes

  1. Engaged in tobacco cessation treatment since end of treatment intervention

    Time frame: 3-months

Secondary outcomes

  1. Number of quit smoking attempts since last assessment

    Time frame: 3-months

Other outcomes

  1. Point prevalence smoking abstinence - last 7 days from time of assessment

    Time frame: 3-months

Sponsors and collaborators

Lead sponsor

Butler Hospital

Other

Registry information

Official study title

Brief Computer Intervention to Motivate Quitline Use for Smokers in SUD Treatment

Acronym: MI-SUD

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
Jun 20, 2013
Registry last updated
Jul 20, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.